Hepatic arterial infusion chemotherapy plus lenvatinib and programmed death receptor 1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombosis: a prospective controlled study

@article{zheng2026hepatic,
  title = {{Hepatic arterial infusion chemotherapy plus lenvatinib and programmed death receptor 1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombosis: a prospective controlled study}},
  author = {Kanglian Zheng and Ming Liu and Xu Zhu and Guang Cao and Liang Xu and Shijie Fu and Yuyang Dai and Peng Liu and Song Gao and Fuxin Kou and Qinzong Gao and Kun Wang and Xiaoluan Yan and Da Xu and Quan Bao and Lijun Wang and Jianhui Wu and Chunyi Hao and Baocai Xing and Xiaodong Wang},
  journal = {BMC Medicine},
  year = {2026},
  month = oct,
  doi = {10.1186/s12916-026-05309-6},
  url = {https://link.springer.com/article/10.1186/s12916-026-05309-6},
  note = {CC BY-NC-ND 4.0},
}

TY  - JOUR
TI  - Hepatic arterial infusion chemotherapy plus lenvatinib and programmed death receptor 1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombosis: a prospective controlled study
AU  - Kanglian Zheng
AU  - Ming Liu
AU  - Xu Zhu
AU  - Guang Cao
AU  - Liang Xu
AU  - Shijie Fu
AU  - Yuyang Dai
AU  - Peng Liu
AU  - Song Gao
AU  - Fuxin Kou
AU  - Qinzong Gao
AU  - Kun Wang
AU  - Xiaoluan Yan
AU  - Da Xu
AU  - Quan Bao
AU  - Lijun Wang
AU  - Jianhui Wu
AU  - Chunyi Hao
AU  - Baocai Xing
AU  - Xiaodong Wang
PY  - 2026
DA  - 2026/10/14
JO  - BMC Medicine
DO  - 10.1186/s12916-026-05309-6
UR  - https://link.springer.com/article/10.1186/s12916-026-05309-6
SN  - 1741-7015
ER  -